# Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn®

> **NCT01063920** · PHASE2,PHASE3 · COMPLETED · sponsor: **Logical Therapeutics** · enrollment: 534 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** LT-NS001
- **DRUG:** Naprosyn®

## Key facts

- **NCT ID:** NCT01063920
- **Lead sponsor:** Logical Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 534 (ESTIMATED)
- **Last updated:** 2011-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063920, "Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn®". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01063920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*